← All stocks

Century Therapeutics, Inc.

IPSC Net buying
CIK 0001850119 #3356 in the set updated 17 Sep 2026
Bought (120 mo)
$32.10M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.23M
$81.25K on a plan · $811.92K straight out of an exercise
Sold at will
$7.34M
49 of 63 sales
Net
+$23.88M
+$24.77M against sales at will

By person

14 insiders · 71 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BAYER AKTIENGESELLSCHAFT
10% owner
$15.00M (1)
+$15.00M
12,675,838
$24.46M
Casdin Eli
Director
$15.00M (1)
+$15.00M
3,206,380
$6.19M
Versant Venture Capital VI, L.P. entity
10% owner
$2.00M (1)
$7.17M (1)
−$5.17M
12,166,109
$23.48M
+308.1%
Borges Luis
Chief Scientific Officer
$539.88K (3) scheduled
−$539.88K
256,535
$495.11K
Farid Adrienne
Chief Operations Officer
$297.10K (12) scheduled
−$297.10K
250,141
$482.77K
+237.0%
Russotti Gregory
See Remarks
$123.44K (18) scheduled
−$123.44K
601,971
$1.16M
+62.2%
Cowan Chad
Chief Scientific Officer
$49.25K (1)
$2.74K (1)
+$46.52K
1,175,322
$2.27M
+763.8%
Carr Douglas
SVP Finance & Operations
$39.76K (22)
−$39.76K
502,907
$970.61K
+171.0%
Pfeiffenberger Brent
President and CEO
$47.68K (2)
$59.96K (6)
−$12.28K
3,633,839
$7.01M
+26,137%
Quimi Daphne
Director
$7.66K (1)
+$7.66K
5,000
$9.65K
FUJIFILM Cellular Dynamics, Inc. entity
10% owner
6,955,207
$13.42M
+133.3%
Diem Michael Craig
Chief Financial Officer
253,533
$489.32K
+219.0%
Conn Morgan
Chief Finanical Officer
79,648
$153.72K
Levitsky Hyam
President of R&D
24,000
$46.32K

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 85,029,042 to 181,075,321 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Farid Adrienne
7 Mar 2024
Chief Operations Officer
Sold after exercise
22,831
$5.14
$117.34K
Farid Adrienne
6 Mar 2024
Chief Operations Officer
Sold after exercise
30,684
$4.96
$152.34K
Farid Adrienne
16 Feb 2024
Chief Operations Officer
Sold after exercise
485
$4.86
$2.36K
Borges Luis
23 Mar 2023
Chief Scientific Officer
Sold after exercise
15,597
$3.55
$55.37K
Borges Luis
22 Mar 2023
Chief Scientific Officer
Sold after exercise
65,698
$3.72
$244.64K
Borges Luis
21 Mar 2023
Chief Scientific Officer
Sold after exercise
63,616
$3.77
$239.87K

What was left out

Form 4 filings counted 162
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 6
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 36,941,556
Sales filed before the plan box existed 1
History held since 21 Jun 2021